KR100694526B1 - 약제학적 조성물 - Google Patents

약제학적 조성물 Download PDF

Info

Publication number
KR100694526B1
KR100694526B1 KR1020017013576A KR20017013576A KR100694526B1 KR 100694526 B1 KR100694526 B1 KR 100694526B1 KR 1020017013576 A KR1020017013576 A KR 1020017013576A KR 20017013576 A KR20017013576 A KR 20017013576A KR 100694526 B1 KR100694526 B1 KR 100694526B1
Authority
KR
South Korea
Prior art keywords
composition
dihydroxy
seco
pregna
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020017013576A
Other languages
English (en)
Korean (ko)
Other versions
KR20010110803A (ko
Inventor
디트릭젠에릭
회이게르트
Original Assignee
레오 파마 에이/에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8094933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100694526(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 레오 파마 에이/에스 filed Critical 레오 파마 에이/에스
Publication of KR20010110803A publication Critical patent/KR20010110803A/ko
Application granted granted Critical
Publication of KR100694526B1 publication Critical patent/KR100694526B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020017013576A 1999-04-23 2000-01-27 약제학적 조성물 Expired - Lifetime KR100694526B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900561 1999-04-23
DKPA199900561 1999-04-23

Publications (2)

Publication Number Publication Date
KR20010110803A KR20010110803A (ko) 2001-12-13
KR100694526B1 true KR100694526B1 (ko) 2007-03-13

Family

ID=8094933

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017013576A Expired - Lifetime KR100694526B1 (ko) 1999-04-23 2000-01-27 약제학적 조성물

Country Status (30)

Country Link
US (1) US6753013B1 (enExample)
EP (5) EP2915534B1 (enExample)
JP (4) JP4426729B2 (enExample)
KR (1) KR100694526B1 (enExample)
CN (1) CN1173703C (enExample)
AU (1) AU774600B2 (enExample)
BG (1) BG65115B1 (enExample)
BR (3) BR122012030847B1 (enExample)
CA (1) CA2370565C (enExample)
CY (5) CY1113967T1 (enExample)
CZ (1) CZ303142B6 (enExample)
DK (5) DK2450043T3 (enExample)
ES (5) ES2674563T3 (enExample)
HK (1) HK1045650B (enExample)
HR (1) HRP20010779B1 (enExample)
HU (1) HU230045B1 (enExample)
IL (2) IL145983A0 (enExample)
IS (1) IS6120A (enExample)
LT (2) LT3146969T (enExample)
ME (1) ME00298B (enExample)
MX (1) MXPA01010676A (enExample)
NO (1) NO329486B1 (enExample)
NZ (1) NZ515142A (enExample)
PL (1) PL199123B1 (enExample)
PT (5) PT2450043T (enExample)
RS (1) RS52182B (enExample)
RU (1) RU2238734C2 (enExample)
SI (3) SI2915534T1 (enExample)
SK (1) SK287653B6 (enExample)
WO (1) WO2000064450A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101641372B1 (ko) * 2015-05-08 2016-07-20 (주)동구바이오제약 안정성과 피부투과율이 향상된 약학 조성물

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
HU230045B1 (hu) * 1999-04-23 2015-06-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Bőrgyógyászati alkalmazásra szolgáló nem vizes gyógyszerkészítmény
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
IL154775A0 (en) * 2000-09-18 2003-10-31 Applied Research Systems 21-hydroxy-6, 19-oxidoprogesterone (21oh-6, 19op) analogues, their preparation and use
PT1331927E (pt) * 2000-10-27 2008-01-30 Leo Pharma As Composição tópica contendo pelo menos uma vitamina d ou um análogo de vitamina d e, pelo menos, um corticosteróide
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
JP2006505583A (ja) 2002-10-25 2006-02-16 フォーミックス エルティーディー． 化粧剤および医薬用フォーム
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20050101576A1 (en) * 2003-11-06 2005-05-12 Novacea, Inc. Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
US7351869B2 (en) * 2002-11-18 2008-04-01 Teva Pharmaceutical Industries Ltd Crystallization method for purification of calcipotriene
BR0315195A (pt) * 2002-12-17 2005-08-23 Galderma Sa Composições farmacêuticas e usos das composições
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
EP1875916A3 (en) * 2002-12-17 2008-01-23 Galderma S.A. Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
JP2004359585A (ja) * 2003-06-03 2004-12-24 Medorekkusu:Kk 被膜形成型の副腎皮質ステロイド薬含有外用製剤
FR2856301B1 (fr) 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
PE20050359A1 (es) * 2003-08-12 2005-06-27 Novartis Consumer Health Sa Composiciones topicas que comprenden terbinafina e hidrocortisona
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
EP1748784A4 (en) * 2004-05-26 2008-02-13 Cedars Sinai Medical Center INDUCTION OF IMMUNITY IN VITAMIN D3 AND ITS ANALOGUES
FR2871693B1 (fr) * 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871695B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
SI1771180T2 (sl) 2004-06-17 2011-02-28 Galderma Sa Zmes v obliki pršila, ki vsebuje kombinacijo klobetazol propionata in kalcitrola, alkoholna faza in oljna faza
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
BRPI0511398A (pt) * 2004-06-17 2007-12-04 Galderma Sa composição farmacêutica anidra para o tratamento da psorìase e uso de um agente siliconado
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
BRPI0511389A (pt) * 2004-06-17 2007-12-04 Galderma Sa composição e seu uso
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
JP2006131544A (ja) * 2004-11-05 2006-05-25 Medorekkusu:Kk 皮膚疾患治療用外用剤
US7244719B2 (en) * 2004-11-22 2007-07-17 Wisconsin Alumni Research Foundation 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
US8034788B2 (en) * 2005-05-10 2011-10-11 Dermipsor Ltd. Composition and methods for skin care
CN101193641B (zh) 2005-05-10 2013-05-29 德米普瑟尔有限公司 用于治疗表皮过度增殖疾病的组合物和方法
NZ563560A (en) 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
CN101400649B (zh) 2006-03-17 2012-07-04 利奥制药有限公司 药物中间体的异构化
ATE444071T1 (de) * 2006-08-17 2009-10-15 Klever Mode S L Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen
JP2010502624A (ja) * 2006-08-29 2010-01-28 テバ ファーマシューティカル インダストリーズ リミティド 低ｐＨ親和性を有するコルチコステロイド化合物及びビタミンＤ含有化合物を含む安定な薬理活性組成物
CA2662864A1 (en) * 2006-09-28 2008-04-03 Wisconsin Alumni Research Foundation 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
JP2010504995A (ja) * 2006-09-28 2010-02-18 ウイスコンシン アラムニ リサーチ ファンデーション ２−メチレン−（２０ｒ，２５ｓ）−１９，２７−ジノル−（２２ｅ）−ビタミンｄ類縁体
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
FR2909284B1 (fr) 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) * 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
PE20110849A1 (es) 2008-10-03 2011-12-02 Nexmed Holdings Inc Composicion estabilizada para el tratamiento de la psoriasis
RU2396081C1 (ru) * 2008-12-29 2010-08-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения дерматозов, поддающихся глюкокортикостероидной терапии, и способ ее получения
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US20100286101A1 (en) * 2009-05-07 2010-11-11 Jason Carbol Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US20110053898A1 (en) * 2009-08-26 2011-03-03 Glenmark Generics Ltd Topical composition comprising vitamin d analogue and corticosteroids
EP3403654B1 (en) 2009-10-01 2019-07-31 Adare Development I, L.P. Orally administered corticosteroid compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
MX2012007225A (es) * 2009-12-22 2012-07-30 Leo Pharma As Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
BR112012030653B1 (pt) 2010-06-11 2021-10-13 Leo Pharma A/S Composição tópica em aerossol, e, recipiente pressurizado
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
SI2686017T1 (sl) 2011-03-14 2019-11-29 Drug Delivery Solutions Ltd Očesna sestava
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
CN103110648A (zh) * 2013-01-25 2013-05-22 江苏圣宝罗药业有限公司 钙泊三醇倍他米松软膏及其制备方法
KR102268357B1 (ko) 2013-01-29 2021-06-23 아벡신 에이에스 항염증성 및 항종양성 2-옥소티아졸 및 2-옥소티오펜 화합물
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CN104666312B (zh) * 2015-02-12 2017-11-07 重庆华邦制药有限公司 含有卡泊三醇和二丙酸倍他米松的制剂
MA41818A (fr) * 2015-03-27 2018-01-30 Leo Pharma As Timbre à micro-aiguilles pour administration d'un principe actif à la peau
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
CN107157920B (zh) * 2016-03-08 2019-12-27 上海通用药业股份有限公司 一种包含维生素d或其衍生物的半固体制剂的制备方法
CN107157918B (zh) * 2016-03-08 2019-12-27 上海通用药业股份有限公司 一种用于银屑病治疗的半固体制剂的制备方法
CN107157919B (zh) * 2016-03-08 2019-12-27 上海通用药业股份有限公司 一种用于治疗银屑病的半固体制剂的制备方法
CN107157917B (zh) * 2016-03-08 2019-12-27 上海通用药业股份有限公司 一种用于治疗银屑病的软膏的制备方法
GB201604318D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
MX377365B (es) 2016-09-08 2025-03-10 Journey Medical Corp Composiciones y métodos para tratar rosácea y acné.
WO2019072353A1 (en) * 2017-10-11 2019-04-18 Elmasry Mohamed Zakria Ahmed Ali TOPICAL PHARMACEUTICAL PREPARATION OF BETAMETHASONE, CALCIPOTRIOL AND ROSE OIL FOR THE TREATMENT OF PSORIASIS
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
FR3083701B1 (fr) 2018-07-13 2020-08-14 Gifrer Barbezat Liniment oleo-alcalin
JP7350985B2 (ja) * 2020-03-19 2023-09-26 シオノギヘルスケア株式会社 ベタメタゾン吉草酸エステル含有組成物
MX2023006638A (es) * 2020-12-04 2023-08-22 Incyte Corp Inhibidor de la cinasa janus (jak) con un análogo de la vitamina d para el tratamiento de enfermedades de la piel.
CN115177586A (zh) * 2022-08-31 2022-10-14 江苏知原药业股份有限公司 一种卡泊三醇组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014453A1 (en) * 1992-12-23 1994-07-07 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Hydroxy vitamin d3 compounds for treating skin atrophy

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB892127A (en) 1958-03-03 1962-03-21 Merck & Co Inc Therapeutic preparations comprising steroids and vitamin d
DK116528A (enExample) * 1966-09-30
US4083974A (en) 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
JP2522962B2 (ja) * 1986-09-19 1996-08-07 中外製薬株式会社 乾癬治療剤
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
GB8821129D0 (en) * 1988-09-09 1988-10-12 Unilever Plc Cosmetic composition
GB8904154D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
US5185150A (en) 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
US5763426A (en) * 1993-01-15 1998-06-09 Leo Pharmaceutical Products Ltd. Crystalline form of a vitamin D analogue
GB9314400D0 (en) * 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
JPH07173053A (ja) * 1993-12-20 1995-07-11 Otsuka Pharmaceut Co Ltd 抗微生物剤
JP3506474B2 (ja) 1994-01-07 2004-03-15 帝人株式会社 安定性の向上した乾癬治療剤
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
US5840925A (en) * 1995-06-29 1998-11-24 Hauser, Inc. Trioxane dimer compounds having antiproliferative and antitumor activities
JPH11514999A (ja) * 1995-10-10 1999-12-21 ストルーブ，マリリン ビタミンｄおよびその誘導体による掻痒症治療
FR2740042B1 (fr) * 1995-10-23 1997-11-14 Oreal Support, et composition contenant ce support et un actif cosmetique ou dermatologique stabilise
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
JPH1067757A (ja) * 1996-06-21 1998-03-10 Ss Pharmaceut Co Ltd トリアゾール誘導体またはその塩
JPH10139669A (ja) * 1996-11-05 1998-05-26 Teijin Ltd 脂漏性角化症治療剤
US6017908A (en) * 1997-05-16 2000-01-25 Women And Infants Hospital 3-EPI vitamin D2 compounds and uses thereof
DE69832699T2 (de) * 1997-05-16 2006-08-24 Woman & Infants Hospital Zyklische äther vitamin d3 verbindungen, 1alfa(oh) 3-epi-vitamin d3 verbindungen und deren verwendungen
KR20010032892A (ko) * 1997-12-09 2001-04-25 나가야마 오사무 비타민 ｄ３유도체를 함유하는 크림제
AU743582B2 (en) * 1997-12-09 2002-01-31 Chugai Seiyaku Kabushiki Kaisha Lotions containing vitamin D3 derivatives
JPH11188054A (ja) * 1997-12-25 1999-07-13 Lion Corp 皮膚外用部材
JPH11246329A (ja) * 1998-02-27 1999-09-14 Shiseido Co Ltd 皮膚外用剤
KR100491202B1 (ko) * 1998-03-04 2005-05-25 데이진 가부시키가이샤 활성형 비타민 ｄ3 유제성 로션제
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US5886038A (en) * 1998-03-24 1999-03-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
HU230045B1 (hu) 1999-04-23 2015-06-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Bőrgyógyászati alkalmazásra szolgáló nem vizes gyógyszerkészítmény

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014453A1 (en) * 1992-12-23 1994-07-07 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Hydroxy vitamin d3 compounds for treating skin atrophy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101641372B1 (ko) * 2015-05-08 2016-07-20 (주)동구바이오제약 안정성과 피부투과율이 향상된 약학 조성물
WO2016182258A3 (ko) * 2015-05-08 2017-01-12 (주)동구바이오제약 안정성과 피부투과율이 향상된 약학 조성물

Also Published As

Publication number Publication date
PT2915534T (pt) 2018-06-20
BG65115B1 (bg) 2007-03-30
EP1178808A1 (en) 2002-02-13
JP5721926B2 (ja) 2015-05-20
ES2432691T3 (es) 2013-12-04
LT3146969T (lt) 2018-09-25
PL351387A1 (en) 2003-04-07
ES2388425T5 (es) 2020-02-12
EP1178808B1 (en) 2012-05-30
BRPI0009956B1 (pt) 2014-11-11
SK15182001A3 (sk) 2002-06-04
BR122012030846B1 (pt) 2021-04-27
KR20010110803A (ko) 2001-12-13
PT2455083E (pt) 2013-10-09
NO329486B1 (no) 2010-10-25
SI2915534T1 (sl) 2018-10-30
AU2278300A (en) 2000-11-10
CY1118206T1 (el) 2017-06-28
ME00298B (me) 2011-05-10
IL145983A0 (en) 2002-07-25
JP5886999B2 (ja) 2016-03-16
EP2450043B1 (en) 2016-08-17
HU230045B1 (hu) 2015-06-29
ES2388425T3 (es) 2012-10-15
ES2671785T3 (es) 2018-06-08
BR122012030846B8 (pt) 2021-05-25
HUP0200879A2 (en) 2002-08-28
CA2370565C (en) 2008-11-25
EP2455083A1 (en) 2012-05-23
BR122012030847B1 (pt) 2021-07-06
PT2450043T (pt) 2016-10-12
ES2602450T3 (es) 2017-02-21
JP2002542293A (ja) 2002-12-10
CY1114420T1 (el) 2016-08-31
JP2008297309A (ja) 2008-12-11
JP4426729B2 (ja) 2010-03-03
HRP20010779A2 (en) 2002-12-31
CZ20013739A3 (cs) 2002-06-12
IL145983A (en) 2006-08-20
DK2450043T3 (en) 2016-09-12
CY1113967T1 (el) 2016-07-27
WO2000064450A1 (en) 2000-11-02
MXPA01010676A (es) 2003-08-20
EP2450043A1 (en) 2012-05-09
CY1120313T1 (el) 2019-07-10
EP2915534A1 (en) 2015-09-09
MEP39108A (en) 2011-02-10
CN1173703C (zh) 2004-11-03
HK1045650B (zh) 2005-04-08
CN1351499A (zh) 2002-05-29
RS52182B (sr) 2012-10-31
PL199123B1 (pl) 2008-08-29
RU2238734C2 (ru) 2004-10-27
SI3146969T1 (en) 2018-08-31
EP3146969A1 (en) 2017-03-29
SI1178808T1 (sl) 2012-10-30
NO20015175D0 (no) 2001-10-23
YU75701A (sh) 2005-07-19
PT1178808E (pt) 2012-08-16
DK2915534T3 (en) 2018-06-14
AU774600B2 (en) 2004-07-01
CY1120659T1 (el) 2019-12-11
LT2915534T (lt) 2018-06-25
ES2674563T3 (es) 2018-07-02
BRPI0009956B8 (pt) 2021-07-06
HUP0200879A3 (en) 2004-04-28
JP2015155451A (ja) 2015-08-27
BRPI0009956A (pt) 2002-01-08
DK3146969T3 (en) 2018-08-27
EP2915534B1 (en) 2018-03-14
HRP20010779B1 (hr) 2011-02-28
CZ303142B6 (cs) 2012-05-02
HK1045650A1 (en) 2002-12-06
JP2013075923A (ja) 2013-04-25
BG106030A (en) 2002-05-31
US6753013B1 (en) 2004-06-22
DK2455083T3 (da) 2013-09-30
DK1178808T3 (da) 2012-07-30
IS6120A (is) 2001-10-22
NZ515142A (en) 2004-01-30
EP3146969B1 (en) 2018-06-20
NO20015175L (no) 2001-10-23
PT3146969T (pt) 2018-10-18
EP2455083B1 (en) 2013-09-18
SK287653B6 (sk) 2011-05-06
EP1178808B2 (en) 2019-06-12
DK1178808T4 (da) 2019-09-02
CA2370565A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
KR100694526B1 (ko) 약제학적 조성물
RU2271810C2 (ru) Композиции местного применения, содержащие, по меньшей мере, один витамин d или один аналог витамина d и, по меньшей мере, один кортикостероид
HK1236104A (en) Ointments for the topical treatment of psoriasis
HK1236104A1 (en) Ointments for the topical treatment of psoriasis
HK1236104B (en) Ointment for the topical treatment of psoriasis
HK1077208B (en) Topical composition containing at least one vitmin d or one vitamin d analogue and at least one corticosteroid

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20011023

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20041022

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060425

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20061218

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20070307

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20070308

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20100304

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20110225

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20120227

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20130225

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20130225

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20140225

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20140225

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20150226

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20150226

Start annual number: 9

End annual number: 9

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20150227

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20070307

Comment text: Registration of Establishment

Decision date: 20151015

Request date: 20150227

Appeal identifier: 2015100000611

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20150402

Comment text: Request for Trial

Decision date: 20151015

Request date: 20150402

Appeal identifier: 2015100001862

Appeal kind category: Confirmation of the scope of right_defensive

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

Patent event code: PJ02062R01D

Patent event date: 20150514

Comment text: Request for Trial

Patent event code: PJ02061E01I

Patent event date: 20070307

Comment text: Registration of Establishment

Request date: 20150514

Appeal identifier: 2015100003203

Appeal kind category: Confirmation of the scope of right_defensive

J204 Request for invalidation trial [patent]
PJ0204 Invalidation trial for patent

Patent event date: 20150527

Comment text: Request for Trial

Patent event code: PJ02042R01D

Patent event date: 20070307

Comment text: Registration of Establishment

Patent event code: PJ02041E01I

Appeal kind category: Invalidation

Request date: 20150527

Appeal identifier: 2015100003325

J301 Trial decision

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20150227

Effective date: 20151015

PJ1301 Trial decision

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20150402

Decision date: 20151015

Appeal identifier: 2015100001862

Patent event code: PJ13011S02D

Patent event date: 20151015

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20150227

Decision date: 20151015

Appeal identifier: 2015100000611

J301 Trial decision

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20150514

Effective date: 20151218

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20150527

Effective date: 20151218

PJ1301 Trial decision

Appeal kind category: Invalidation

Request date: 20150527

Decision date: 20151218

Appeal identifier: 2015100003325

Patent event code: PJ13011S05D

Patent event date: 20151218

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Patent event code: PJ13011S02D

Patent event date: 20151218

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20150514

Decision date: 20151218

Appeal identifier: 2015100003203

J2X1 Appeal (before the patent court)

Free format text: INVALIDATION

Free format text: CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE

PJ2001 Appeal

Appeal kind category: Confirmation of the scope of right_defensive

Appeal identifier: 2016200000717

Request date: 20160201

Patent event date: 20151218

Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S05I

Patent event date: 20151218

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S02I

Patent event date: 20151015

Comment text: Trial Decision for Confirmation of the Scope of a Right (Patent, Utility Model, Industrial Design)

Patent event code: PJ20011S02I

Appeal kind category: Invalidation

Appeal identifier: 2016200000700

Request date: 20160201

FPAY Annual fee payment

Payment date: 20160224

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20160224

Start annual number: 10

End annual number: 10

J302 Written judgement (patent court)

Free format text: TRIAL NUMBER: 2016200000717; JUDGMENT (PATENT COURT) FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160201

Effective date: 20161013

Free format text: TRIAL NUMBER: 2016200000700; JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20160201

Effective date: 20161013

PJ1302 Judgment (patent court)

Request date: 20160201

Decision date: 20161013

Appeal identifier: 2016200000717

Appeal kind category: Confirmation of the scope of right_defensive

Patent event date: 20161109

Comment text: Written Judgment (Patent Court)

Patent event code: PJ13021S01D

Request date: 20160201

Decision date: 20161013

Appeal identifier: 2016200000700

Appeal kind category: Invalidation

PJ2201 Remand (intellectual property tribunal)

Request date: 20161109

Appeal kind category: Invalidation

Appeal identifier: 2016130000140

Patent event code: PJ22012S01I

Comment text: Written Judgment (Patent Court)

Patent event date: 20161109

Request date: 20161109

Appeal kind category: Confirmation of the scope of right_defensive

Appeal identifier: 2016130000139

J301 Trial decision

Free format text: TRIAL NUMBER: 2016130000139; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20161109

Effective date: 20170110

PJ1301 Trial decision

Appeal kind category: Invalidation

Request date: 20161109

Decision date: 20170110

Appeal identifier: 2016130000140

Patent event code: PJ13011S09D

Patent event date: 20170110

Comment text: Trial Decision on Final Judgment on Revocation

Appeal kind category: Confirmation of the scope of right_defensive

Request date: 20161109

Decision date: 20170110

Appeal identifier: 2016130000139

FPAY Annual fee payment

Payment date: 20180227

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20180227

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20190226

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20190226

Start annual number: 13

End annual number: 13

PC1801 Expiration of term

Termination date: 20200727

Termination category: Expiration of duration